Pharmacokinetics and pharmacodynamics of glibenclamide in type 2 diabetics.
Virendra Rambiritch
Abstract
Open-access reader
Virendra Rambiritch
Abstract
Open-access reader
Dr Colin Pillai, supervisor, colleague, role model and friend, for sharing your knowledge of pharmacokinetics and pharmacodynamics, and modeling and simulation.You have elevated this science to a new level of recognition.The completion of this dissertation is a monument to your dedicated precision and resolve.Thanks for your total commitment.• ProfB Maharaj, for the constant encouragement throughout the study.• Dr L Robertson, for the initial investigation
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Dr Colin Pillai, supervisor, colleague, role model and friend, for sharing your knowledge of pharmacokinetics and pharmacodynamics, and modeling and simulation.You have elevated this science to a new level of recognition.The completion of this dissertation is a monument to your dedicated precision and resolve.Thanks for your total commitment.• ProfB Maharaj, for the constant encouragement throughout the study.• Dr L Robertson, for the initial investigation
Key concepts: Glibenclamide, Pharmacodynamics, Pharmacokinetics, Medicine, Type 2 diabetes, Pharmacology, Diabetes mellitus, Endocrinology